Earnings
Home›Earnings›Analyst Ratings›Achieve Life Sciences shares jump after fresh technica…
Achieve Life Sciences shares jump after fresh technical buy signal
The stock gained 16.8% since a June 25 “Buy” signal, though the company has yet to monetize its research pipeline.
Achieve Life Sciences (ACHV) has nearly tripled over the past year and recently drew another technical “Buy” signal, according to analysis published by Yahoo Finance.
The June 25 signal came from Trend Seeker, and the shares have since climbed 16.8%, while the outlet describes the stock as highly speculative because it has not yet started monetizing its research pipeline for cytisinicline-based nicotine addiction treatments.
The article places Achieve Life Sciences valuation at $685 million and notes that Wall Street analysts tracked by Barchart have issued eight “Strong Buy” opinions with price targets ranging from $10 to $21.
Even with the positive technical momentum, Yahoo Finance cautions that the company is not yet monetizing its pipeline, emphasizing the volatility and speculative nature of the stock.